Your browser doesn't support javascript.
loading
Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.
Kashyap, Manoj K; Amaya-Chanaga, Carlos I; Kumar, Deepak; Simmons, Brett; Huser, Nanni; Gu, Yin; Hallin, Max; Lindquist, Kevin; Yafawi, Rolla; Choi, Michael Y; Amine, Ale-Ali; Rassenti, Laura Z; Zhang, Cathy; Liu, Shu-Hui; Smeal, Tod; Fantin, Valeria R; Kipps, Thomas J; Pernasetti, Flavia; Castro, Januario E.
Afiliação
  • Kashyap MK; Moores Cancer Center, University of California San Diego, 3855 Health Science Drive, La Jolla, CA, 92093-0820, USA.
  • Amaya-Chanaga CI; Moores Cancer Center, University of California San Diego, 3855 Health Science Drive, La Jolla, CA, 92093-0820, USA.
  • Kumar D; Moores Cancer Center, University of California San Diego, 3855 Health Science Drive, La Jolla, CA, 92093-0820, USA.
  • Simmons B; Oncology Research & Development, Pfizer Worldwide Research & Development, 10646 Science Center Drive, San Diego, CA, 92121, USA.
  • Huser N; Oncology Research & Development, Pfizer Worldwide Research & Development, 10646 Science Center Drive, San Diego, CA, 92121, USA.
  • Gu Y; Oncology Research & Development, Pfizer Worldwide Research & Development, 10646 Science Center Drive, San Diego, CA, 92121, USA.
  • Hallin M; Oncology Research & Development, Pfizer Worldwide Research & Development, 10646 Science Center Drive, San Diego, CA, 92121, USA.
  • Lindquist K; Present Address: Mirati Therapeutics, San Diego, CA, USA.
  • Yafawi R; Oncology Research & Development-Rinat Biotechnology Unit, Pfizer Worldwide Research & Development, South San Francisco, CA, USA.
  • Choi MY; Drug Safety Research & Development, Pfizer Worldwide Research & Development, La Jolla, CA, USA.
  • Amine AA; Moores Cancer Center, University of California San Diego, 3855 Health Science Drive, La Jolla, CA, 92093-0820, USA.
  • Rassenti LZ; CLL Research Consortium, and Department of Medicine, University of California San Diego, La Jolla, CA, USA.
  • Zhang C; Moores Cancer Center, University of California San Diego, 3855 Health Science Drive, La Jolla, CA, 92093-0820, USA.
  • Liu SH; Moores Cancer Center, University of California San Diego, 3855 Health Science Drive, La Jolla, CA, 92093-0820, USA.
  • Smeal T; CLL Research Consortium, and Department of Medicine, University of California San Diego, La Jolla, CA, USA.
  • Fantin VR; Oncology Research & Development, Pfizer Worldwide Research & Development, 10646 Science Center Drive, San Diego, CA, 92121, USA.
  • Kipps TJ; Oncology Research & Development-Rinat Biotechnology Unit, Pfizer Worldwide Research & Development, South San Francisco, CA, USA.
  • Pernasetti F; Oncology Research & Development, Pfizer Worldwide Research & Development, 10646 Science Center Drive, San Diego, CA, 92121, USA.
  • Castro JE; Present Address: Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
J Hematol Oncol ; 10(1): 112, 2017 05 19.
Article em En | MEDLINE | ID: mdl-28526063
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Leucemia Linfocítica Crônica de Células B / Receptores CXCR4 / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Leucemia Linfocítica Crônica de Células B / Receptores CXCR4 / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos